共 50 条
- [1] First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid TumorsCLINICAL CANCER RESEARCH, 2017, 23 (19) : 5703 - 5710Papadopoulos, Kyriakos P.Gluck, LarryMartin, Lainie P.Olszanski, Anthony J.Tolcher, Anthony W.Ngarmchamnanrith, GatareeRasmussen, ErikAmore, Benny M.Nagorsen, DirkHill, John S.Stephenson, Joe, Jr.
- [2] First-in-human study of AMG 208, an oral MET inhibitor, in adult patients (pts) with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)Hong, David S.Rosen, Peter J.Lockhart, A. CraigFu, SiqingJanku, FilipKurzrock, RazelleKhan, RabiaAmore, BennyCaudillo, IsaacDeng, HongjieHwang, Yuying C.Loberg, Robert D.Shubhakar, PoornimaZoog, StephenBeaupre, Darrin M.Lee, Peter
- [3] A Phase 1 first-in-human study of MEDI0680, an anti-PD-1 monoclonal antibody (mAb) in adult patients (pts) with advanced tumorsANNALS OF ONCOLOGY, 2016, 27Naing, A.Goel, S.Curti, B.Weise, A.Eder, J. P.Marshall, S.Morehouse, C.Li, X.Karakunnel, J. J.Infante, J.
- [4] First-in-human study of AMG 337, a highly selective oral inhibitor of MET, in adult patients (pts) with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Hong, David S.LoRusso, PatriciaHamid, OmidBeaupre, Darrin M.Janku, FilipKhan, RablaKittaneh, MualadLoberg, Robert D.Amore, BennyCaudillo, IsaacHwang, Yuying C.Tang, RuiMgarmchamnanrith, GatareeKwak, Eunice Leo
- [5] First-in-human study of AMG 900, an oral pan-Aurora kinase inhibitor, in adult patients (pts) with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Carducci, Michael AnthonyShaheen, Montaser F.Paller, Channing JudithBauman, Julie E.Azad, Nilofer SabaShubhakar, PoornimaTang, RuiStroh, MarkFriberg, Gregory R.Verschraegen, Claire F.
- [6] Interim results from a first-in-human study with AMG102, a fully human monoclonal antibody that neutralizes hepatocyte growth factor (HGF), the ligand to c-Met receptor, in patients (pts) with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Gordon, M. S.Mendelson, D. S.Sweeney, C.Erbeck, N.Patel, R.Kakkar, T.Yan, L.Eckhardt, S. G.Gore, L.
- [7] A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumorsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 1039 - 1046Mateo, J.Berlin, J.de Bono, J. S.Cohen, R. B.Keedy, V.Mugundu, G.Zhang, LianglinAbbattista, A.Davis, C.Stampino, C. GalloBorghaei, H.
- [8] Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor-Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid TumorsCLINICAL CANCER RESEARCH, 2010, 16 (02) : 699 - 710Gordon, Michael S.Sweeney, Christopher J.Mendelson, David S.Eckhardt, S. GailAnderson, AbrahamBeaupre, Darrin M.Branstetter, DanielBurgess, Teresa L.Coxon, AngelaDeng, HongjieKaplan-Lefko, PaulaLeitch, Ian M.Oliner, Kelly S.Yan, LucyZhu, MinGore, Lia
- [9] A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumorsCancer Chemotherapy and Pharmacology, 2014, 74 : 1039 - 1046J. MateoJ. BerlinJ. S. de BonoR. B. CohenV. KeedyG. MugunduLianglin ZhangA. AbbattistaC. DavisC. Gallo StampinoH. Borghaei
- [10] A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumorsONCOTARGET, 2015, 6 (21) : 18693 - 18706Hong, David S.Rosen, PeterLockhart, A. CraigFu, SiqingJanku, FilipKurzrock, RazelleKhan, RabiaAmore, BennyCaudillo, IsaacDeng, HongjieHwang, Yuying C.Loberg, RobertNgarmchamnanrith, GatareeBeaupre, Darrin M.Lee, Peter